Cardiotext Logo
Hello, Guest.
Cardiotext Rewards Program Free Shipping on domestic orders of $99.00 or more McAfee Secure sites help keep you safe from identity theft, credit card fraud, spyware, spam, viruses and online scams
Product Detail

Evidence-Based Cardiology

Salim Yusuf; Bernard Gersh


Shipping Calculator

Request a Quote for 10+ Copies

Tell A Friend

More Info...
Evidence-Based Cardiology Retail Price: $199.95
Cardiotext Price: $195.95

Availability: Processing time varies. Price is tentative.

Alert me when this product is available
Availability Questions?


Product Information:
ISBN-13: 9780727916990
ISBN-10: 0727916998
Publisher: BMJ PUBLISHING GROUP
Format: Hardcover
Pub Date: 01/2003
Edition Number: 2




Synopsis

This is the second edition of this clinical cardiology text with an emphasis on rigorous evidence addresses. Chapters written by leading workers discuss best practice in the light of systematic reviews and randomised control trials, and how best to treat where the information is less clear. Case histories provide intriguing discussions on how to apply the evidence in real life situations. The book is kept up to date with its own free website where the latest evidence is automatically posted.



Similar Items



Customer Reviews
Be the first to review this product



Browse Titles In Related Subjects

Additional Description

Approaches to evaluating evidence.

A critical appraisal of the cardiovascular history and physical examination.

Obtaining incremental information from diagnosis tests.

Finding current best evidence to practice evidence based cardiology.

Understanding concepts related to health economics.

Introduction to decision analysis.

Assessing and changing cardiovascular clinical practices.

Learning from clinical practice.

Global perspective on cardiovascular disease.

Tobacco: global burden and community solutions.

Tobacco and cardiovascular disease.

Use of lipid lowering agents in the prevention of cardiovascular disease.

Use of lipid lowering agents in the prevention of cardiovascular disease.

Blood pressure and cardiovascular disease.

Glucose abnormalities and cardiovascular disease: dysglycemia as an emerging cardiovascular risk fac.

Physical activity and exercise in cardiovascular disease prevention and rehabilitation.

Psychosocial factors in the primary and secondary prevention of coronary heart disease: a sys review.

Emerging approaches in cardiovascular prevention.

Cost-effectiveness of prevention of cardiovascular disease.

Estrogens and cardiovascular disease.

Ethnicity and cardiovasculr disease.

Anti-ischemic drugs.

Chronic coronary artery disease: coronary artery bypass surgery vs percutaneous transluminal.

coronary angioplasty vs medical therapy.

Unstable angina.

Thrombolytic therapy.

Mechanical reperfusion strategies in patients presenting with acute myocardial infarction.

Adjunctive antithrombotic therapy for acute myocardial infarction.

Pain relief, general management and other adjunctive treatments.

Complications after myocardial infarction.

An integrated approach to the management of patients after the acute phase of myocardial infarction.

Atrial fibrillation: anti-arrhythmic therapy.

Atrial fibrillation: antithrombotic therapy.

Strial fibrillation: non-pharmacologic therapies.

Supraventricular thachycardia: drugs vs ablation.

Therapy for primary prevention of life threatening ventricular arrythmias.

Impact of pace-makers: when and what kind.

Syncope.

Management of overt heart failure.

Acute myocarditis and dilated cardiomyopathy.

Prevention of congestive heart failure and treatment of asymptomatic left ventricular dysfunction.

Hypertrophic cardiomyopathy.

Other cardiomyopathies.

Pericardial disease: an evidence-based approach to diagnosis and treatment.

Rheumatic heart disease: prevention and acute treatment.

Mitral valve disease.

Indications for surgery in aortic valve disease.

Balloon valvuloplasty: aortic valve.

Balloon valvuloplasty: mitral valve.

Valve repair and choice of valves.

Diagnosis and management of infective endocarditis.

Antithrombotic therapy after heart valve replacement.

Pregnancy in heart disease.

Coronary intervention: angioplasty, stents and atherectomy.

Adjunctive therapy in PTCA.

Restenosis: etiologies and prevention.

The prevention of ischemic stroke.

Venous thromboembolic disease.

Peripheral vascular disease.

Stable angina: choice of PTCA vs CABG vs drugs.

Unstable angina: management issues.

Postmyocardial infarction: routine prophylaxis.

Postmyocardial infarction risk factor modification: dyslipoproteinemias.

Peripheral vasculae disease with suspect coronary artery disease: management issues.

Congestive heart failure.

Atrial fibrillation: management issues.

Ventricular dysrhythmias: pharmacology vs non-pharmacology treatment.

Bradyarrythmias: choice of pacemaker.

Valvular heart disease: timing of surgery.

Clinical trials and meta analysis.

Fetal origins of cardiovascular disease.

Genetics.

Obesity.

CPR chapter.

Introduction to clinical applications